Drug Profile
Ivermectin orally dissolvable strips - Oak Therapeutics
Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Oak Therapeutics
- Developer Oak Therapeutics; University of Southern California
- Class Antimalarials; Antineoplastics; Antiparasitics; Antivirals; Macrolides; Skin disorder therapies; Small molecules
- Mechanism of Action Chloride channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Onchocerciasis
Most Recent Events
- 28 Oct 2021 No recent reports of development identified for preclinical development in Onchocerciasis in USA (PO, Film)
- 04 Sep 2017 Preclinical trials in Onchocerciasis in USA (PO) (Oak Therapeutics pipeline, September 2017)